Correlation Between TC BioPharm and CSL
Can any of the company-specific risk be diversified away by investing in both TC BioPharm and CSL at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining TC BioPharm and CSL into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between TC BioPharm plc and CSL, you can compare the effects of market volatilities on TC BioPharm and CSL and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in TC BioPharm with a short position of CSL. Check out your portfolio center. Please also check ongoing floating volatility patterns of TC BioPharm and CSL.
Diversification Opportunities for TC BioPharm and CSL
0.77 | Correlation Coefficient |
Poor diversification
The 3 months correlation between TCBPW and CSL is 0.77. Overlapping area represents the amount of risk that can be diversified away by holding TC BioPharm plc and CSL in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on CSL and TC BioPharm is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on TC BioPharm plc are associated (or correlated) with CSL. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of CSL has no effect on the direction of TC BioPharm i.e., TC BioPharm and CSL go up and down completely randomly.
Pair Corralation between TC BioPharm and CSL
Assuming the 90 days horizon TC BioPharm plc is expected to generate 25.54 times more return on investment than CSL. However, TC BioPharm is 25.54 times more volatile than CSL. It trades about 0.08 of its potential returns per unit of risk. CSL is currently generating about -0.25 per unit of risk. If you would invest 2.50 in TC BioPharm plc on September 23, 2024 and sell it today you would lose (0.99) from holding TC BioPharm plc or give up 39.6% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Significant |
Accuracy | 97.67% |
Values | Daily Returns |
TC BioPharm plc vs. CSL
Performance |
Timeline |
TC BioPharm plc |
CSL |
TC BioPharm and CSL Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with TC BioPharm and CSL
The main advantage of trading using opposite TC BioPharm and CSL positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if TC BioPharm position performs unexpectedly, CSL can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CSL will offset losses from the drop in CSL's long position.TC BioPharm vs. Protagenic Therapeutics | TC BioPharm vs. bioAffinity Technologies Warrant | TC BioPharm vs. American Rebel Holdings | TC BioPharm vs. Alvotech Warrant |
CSL vs. Nova Mentis Life | CSL vs. PsyBio Therapeutics Corp | CSL vs. HAVN Life Sciences | CSL vs. TC BioPharm plc |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Other Complementary Tools
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |